IMDX Earnings — Insight Molecular Diagnostics Inc. Common Stock Post-ER Performance | BigEarnings
IMDX — Insight Molecular Diagnostics Inc. Common Stock
XNAS · Healthcare · Diagnostics & Research
Price$6.53
Market Cap$207.0M
P/E—
52W Range$2.33 – $8.51
Next Earnings2026-08-10
About Insight Molecular Diagnostics Inc. Common Stock
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.